Summary The prognostic significance of argyrophilic nucleolar organiser regions (AgNORs) 
The analysis of nucleolar organiser regions (NORs), loops of DNA which transcribe to ribosomal RNA (Gall & Pardue, 1969) , has been recently introduced in surgical pathology. Different NOR patterns give information about nucleolar structure and activity in hyperplastic and neoplastic conditions (Walker, 1988) and may be useful for distinguishing benign and malignant cells. Small size, large number and scattered distribution of NORs are characteristic of malignant tumours; large size, small number and clustered distribution are characteristic of benign tumours (Crocker & Nar, 1987; Crocker & Skilbeck, 1987; Derenzini et al., 1988; Smith & Crocker, 1988) . This technique allows also retrospective studies, as proteins associated with NORs can be detected by a simple one-step argyrophilic technique (AgNOR staining), even in routinely fixed and paraffin wax-embedded tissue sections (Ploton et al., 1986). Interest in this method has recently increased since a correlation between AgNOR content and prognosis has been observed in neuroblastoma (Egan et al., 1988b) , prostatic cancer (Contractor et al., 1989) , breast carcinomas (Sivridis & Sims, 1990) and colorectal carcinomas (Ofner et al., 1990; Riischoff et al., 1990) .
Another histopathological feature which has been associated with the prognosis of malignant tumours is the lymphoid stromal infiltration (Underwood, 1974) : carcinomas of the larynx and hypopharynx with heavy lymphocyte infiltrates have a better prognosis (Bennett et al., 1971) ; particularly a high number of intratumoural T-lymphocytes was found to be a good prognostic sign (Shimokawara et al., 1982; Cohen et al., 1987) .
The expression of tumour-associated antigens has also been associated with survival. HMFG-2, a monoclonal antibody which detects a glycoprotein of the cell membrane (Taylor-Papadimitriou et al., 1981) , has been used for prognostic studies in cancer of the larynx (Cortesina et al., 1989) and pharynx (Navone et al., 1989) . 
Materials and methods
The study was performed in 61 patients who underwent biopsy for pharyngeal carcinoma. Ten were females, 51 males. The mean age was 59.4 year . Twenty-four carcinomas were from oropharynx, 19 from hypopharynx and 18 from nasopharynx. The cases were classified according WHO (Shanmugaratnam & Sobin, 1978) and histopathologically graded and clinically staged according to UICC (Hermanek & Sobin, 1987 
Immunohistochemistry
Immunostaining was performed by the ABC method (Hsu et al., 1981) . Sections were dewaxed, rehydrated and brought to phosphate-buffered saline. Endogenous peroxidase activity was blocked by incubation for 30 min in methanol with 0.5% H202.
Monoclonal antibodies against HMFG-2 (kindly supplied by Dr J. Taylor-Papadimitriou), against B lymphocytes (LN2, MB2 from Biotest Clonab°) and T lymphocytes (UCHL1 from Dakopatts°) were used. LN2 and MB2 were diluted 1:2, UCHLI was diluted 1:200, HMFG-2 was diluted in PBS at a concentration of 10 ,tg ml-'; all antisera were incubated overnight. Normal mouse serum was substituted for primary antibodies as a negative control. The sections were then incubated for 30 min with biotin-labelled second layer antibody and avidin-biotin-peroxidase complex (Dakopatts 0) was added. Sections were developed with diaminobenzidine for 10 min, counterstained with hematoxylin and mounted in DPX (BDH Chemicals, Poole, UK).
The percentage of UCHL1, LN2, MB2 positive lymphocytes in the infiltrate and of neoplastic cells stained by HMFG-2 antibody was determined by counting the positive cells and the unreactive cells at a magnification of 400 x. Five different areas were selected for evaluating the HMFG-2 positive cells (about 200 cells). From five to 15 different areas, according to the extent of the lymphocytic infiltrate, were selected for assessing the immunophenotype of lymphocytes (about 100 positive cells).
Statistical analysis
Association between AgNOR scores, and tumour histological grade and/or clinical stage was estimated by one-way analysis of variance (ANOVA).
Univariate survival analyses were based on the KaplanMeier product-limit estimates of survival distribution (Kaplan & Meier, 1958) .
Differences between survival curves were tested statistically using the generalised Wilcoxon test (Gehan, 1965) . The relative importance of multiple prognostic factors on survival was estimated using the Cox proportional hazards regression model (Cox, 1972 (Figure 1) . Few large irregular granules were formed of many small AgNORs (five or more) and were mainly located in the nucleoli; many small single 'dots' were also dispersed in the nucleus. Careful focusing was necessary to identify small single dots within blebs. The results are summarised in Table I. Even though the mean number of AgNORs per cell was higher in more advanced (T4) stage carcinomas (Figure 2) , the ANOVA showed no significant association between AgNOR number and histologic grade (P = 0.08), T stage (P = 0.18) and N status (P = 0.9). Univariate survival analysis The overall 3 and 5 year survivals rates were 51 % and 44%. The median of the survival was 36 months (3-132). The number of AgNOR per cell strongly correlated with the patients outcome at 3-5 year follow-up (P< 0.001) (Table II and Figure 3 ). The median of survival for cases with < 10.31 NOR/cell was 57 months; for cases with > 10.31 NOR/cell it was 20 months. Hypopharyngeal carcinomas had the worst prognosis (5 year survival rate of 32% vs 49% of oropharyngeal and 52% of rhinopharyngeal). T4 stage cases had a 5 year survival rate of 25% vs 40-52% of the other stages. N3 patients had a 5 year survival rate of 30% vs 52-62% of NO and NI. The 5 year survival for G2 carcinomas (40%) was worse than that of G3 carcinomas (52%); these differences however were not statistically significant. The extent of the lymphocytic infiltrate and the immunophenotype of the infiltrating lymphocytes did not significantly correlate with prognosis: cases with mild lymphocytic infiltrate had a 5 year survival rate of 52.5% vs 42% for cases with heavy lymphocytic infiltration (P = 0.76); cases with many UCHL-1 positive T lymphocytes had a 5 year survival rate of 50% vs 40% for cases with few lymphocytes (P = 0.54); cases with relatively numerous LN2, MB2 positive B lymphocytes showed a 5 year survival rate of 50% vs 42-45% for cases with few B lymphocytes (P = 0.43; P = 0.47). Carcinomas with more than 50% of HMFG-2 positive neoplastic cells had a 5 year survival rate of 40% vs 52% for cases with a lesser HMFG-2 positivity (P = 0.29). Patients age and sex were also not significantly correlated with prognosis, even though the 5 year survival rate was better in females (59%) than in males (42%) (P = 0.16) and in the older age group (50%) than in the younger group (42%) (P = 0.76) (Table III) .
When the 18 nasopharyngeal carcinomas were separately analysed, none of the previous parameter significantly correlated with prognosis. The 5 year survival rate for cases with < 10.31 NOR/cell was 70% vs 20% for cases with > 10.31 NOR/cell. However the significance of AgNOR counts was limited to 10% (Mantel-Cox Test = 2.77; P = 0.09). When the remaining 43 oro-hypopharyngeal carcinomas were separately analysed, the only significant prognostic parameters was the AgNOR counts: cases with < 10.31 NOR/cell had a 5 year survival rate of 67% vs 17% for cases with > 10.31 NOR/cell (P = 0.0001).
Multivariate survival analysis To determine if AgNOR count was an independent prognostic variable in pharyngeal carcinoma, a multivariate analysis was performed. By testing the association of response with covariates in the Cox model, only two variables showed significant correlation with prognosis in the whole series: AgNOR counts (P<0.001) and, to a lesser degree, the extent of the lymphocytic infiltration (P = 0.027). The multivariate survival analysis of the 18 nasopharyngeal carcinomas, separately evaluated, showed a high significance of the covariate AgNOR counts (P= 0.007); the extent of the lymphocytic infiltration was also significant (P = 0.018). The multivariate survival analysis of the remaining 43 oro-hypopharyngeal carcinomas indicated the AgNOR counts as the only significant parameter (P <0.001) (Table IV) .
Discussion
The AgNOR analysis of our pharyngeal carcinomas is in line with the results obtained in non-Hodgkin's lymphomas (Crocker & Nar, 1987) , melanocytic lesions (Crocker & Skilbeck, 1987) , epithelial tumours of human intestine (Derenzini et al., 1988) and breast tumours (Smith & Crocker, 1988) . In fact the most differentiated pharyngeal carcinomas showed a relatively large size and clustered distribution of NORs, while the less differentiated carcinomas showed small size and scattered distribution of NORs. (Bryan et al., 1989) , in renal adenomas and carcinomas (Bryan et al., 1990) , in colorectal carcinomas (Riischoff et al., 1990 ) and in renal cell carcinomas (Pich et al., 1991 (1990) in breast carcinomas. These conflicting results may be due to the relatively low number of Ni and N2 carcinomas in our series, to the lack of the pathological staging of our cases and to the partly different methods of evaluation of the silver staining. However, even though more sophisticated techniques which could improve evaluation of AgNOR staining, such as image analysis, have recently been applied to cytologic and histologic preparations (Derenzini et al., 1989; Ruschcoff et al., 1989; Ruschoff et al., 1990) , our counting procedure is substantially similar to the well established method used by most authors (Crocker & Nar, 1987; Crocker & Skilbeck, 1987; Derenzini et al., 1988; Smith & Crocker, 1988; Bryan et al., 1990) , that has always given consistent and reproducible results.
We have clearly demonstrated that AgNOR count is an important variable predicting survival in our series of pharyngeal carcinomas. Even though the univariate survival analysis of our cases of nasopharyngeal carcinomas showed a significance of the AgNOR counts limited to 10%, the multivariate analysis demonstrated a high significance of the covariate AgNOR (P <0.01): the discrepancy can be explained by the small number of cases (18) and events (eight deaths). Moreover, the uni-and multivariate survival analysis of the remaining 43 oro-hypopharyngeal carcinomas showed that AgNOR count was the only significant parameter. This result is in accordance with the data obtained in other types of tumours: childhood neuroblastomas (Egan et al., 1988b) , prostatic cancer (Contractor et al., 1989) and colorectal carcinomas (Ofner et al., 1990; Ruschoff et al., 1990) . The prognostic significance of AgNOR counts may be due to their correlation with cell proliferation: in non-Hodgkin's lymphoma (Hall et al., 1988) and breast carcinomas there is a clear correlation between AgNOR staining and Ki67 immunostaining; cells positive for Ki67 have high AgNOR counts, while Ki67 negative cells contain only one or two AgNORs (Murray et al., 1989 ); a linear relationship was found between cell duplication activity and the amount of AgNOR proteins in cell lines derived from different tumour types (Derenzini et al., 1990) . However, in renal cell carcinomas such correlation is only slightly significant (Pich et al., 1991) and in non-neoplastic tissues AgNOR counts seem to reflect a ploidy rather than cell proliferation (Suresh et al., 1990) .
Our findings are in agreement with studies on a large series of head and neck cancer, in which the labelling index, representing the percentage of proliferating cells, was highly related with survival, while not correlated with tumour histologic grade (Chauvel et al., 1989) .
The correlation between the extent of lymphocytic infiltration and prognosis, observed in many malignant tumours (Underwood, 1974) , has failed to be clearly demonstrated in our series of pharyngeal carcinomas. In fact the multivariate survival analysis of the whole series showed a weak correlation (P = 0.027) that was not confirmed by the univariate survival analysis (P = 0.76 Hsu et al. (1987) who found that the prognosis of rhinopharyngeal keratinizing squamous cell carcinomas (KS) was worse than that of non-keratinizing (NK) or undifferentiated (UD) forms, the 5-year survival rate of our G2 carcinomas was 40% and that of G3 was 52%. The differences however are not statistically significant. But in our limited series all the cases were G2 or G3 carcinomas and also the abovementioned Authors did not find significative differences between NK and UD survivals.
The survival rate of our T4 tumours was lower than that of TI, T2, T3, even though not statistically significant. Also other Authors (Fletcher, 1973; Crissman et al., 1984; Wolf et al., 1984; Moore et al., 1986) have indicated the limited predictive value of the surface diameter in most oral cancers, especially in those of intermediate size (Moore et al., 1986) . In our series the 64% of the carcinomas were T2 and T3; moreover the size of the tumour, when clinically evaluated like as in our cases, lumps the biologically aggressive with the indolent tumours (Moore et al., 1986) .
We did not find significant association between N status and outcome, even though the 5 year-survival rate of NO carcinomas was higher than that of N3 cases (52% vs 30%). This may be due to the relatively low number of Ni and N2 carcinomas and to the lack of pathologic staging of the cases. In fact the clinical evaluation of nodal spread is often erroneous (Sako et al., 1964) and mixes reactive with metastatic lymph node enlargement (Moore et al., 1986) .
The results concerning the diagnostic and prognostic value of AgNOR staining are still conflicting, as a variable degree of overlapping AgNOR has been found in benign and malignant tumours (Nairn et al., 1988; Cronin et al., 1989; Howat et al., 1989; McNicol et al., 1989; Ooms et al., 1989; Hansen & Ostergard, 1990) and no prognostic significance was observed in embryonal rhabdomyosarcoma (Egan et al., 1988a) , thick cutaneous malignant melanoma (Howat et al., 1988) and rectal adenocarcinoma (Griffiths et al., 1989) . However, our findings indicate that at least for pharyngeal carcinomas the AgNOR counts offer a convincing evidence of their prognostic value.
More controlled and standardised technical procedures and new analysis methods could improve AgNOR staining and favour its diffusion as a diagnostic and prognostic tool.
